Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: ALNYLAM PHARMACEUTICALS
Firm Income Reported for This Client
$2.7M
Not substituted for client expenses
Summary
ALNYLAM PHARMACEUTICALS is an organization, based in MA. Its political footprint includes $2.7 million in lobbying-firm income reported for this client. Lobbying activity focuses on Medicare/Medicaid, Health Issues, Pharmacy, Copyright/Patent/Trademark. Political activity spans from 2005 to 2025.